nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A population-level analysis of nonsquamous penile cancer: The importance of histology
|
Bhambhvani, Hriday P. |
|
|
39 |
2 |
p. 136.e1-136.e10 |
artikel |
2 |
Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage
|
Chen, Chuan-Shu |
|
|
39 |
2 |
p. 132.e13-132.e26 |
artikel |
3 |
At a time of global BCG shortage, attempts at optimizing BCG dose and schedule is no longer the answer
|
Morales, Alvaro |
|
|
39 |
2 |
p. 137-138 |
artikel |
4 |
Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer
|
Sfakianos, John P. |
|
|
39 |
2 |
p. 121-129 |
artikel |
5 |
BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review
|
Cabas, Paolo |
|
|
39 |
2 |
p. 85-92 |
artikel |
6 |
Clinical utility of the AJCC 8th edition pT1 subclassification and impact on practice patterns in stage I seminoma
|
Badia, Rohit R. |
|
|
39 |
2 |
p. 136.e19-136.e25 |
artikel |
7 |
Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma
|
Bearrick, Elizabeth N. |
|
|
39 |
2 |
p. 135.e1-135.e8 |
artikel |
8 |
External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA
|
Stolzenbach, Lara Franziska |
|
|
39 |
2 |
p. 131.e1-131.e7 |
artikel |
9 |
“Future role of [18F]-FDG PET/CT in patients with bladder cancer in the new era of neoadjuvant immunotherapy?”
|
Girard, Antoine |
|
|
39 |
2 |
p. 139-141 |
artikel |
10 |
Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients
|
Sun, Maxine |
|
|
39 |
2 |
p. 130.e17-130.e24 |
artikel |
11 |
Impact of neuraxial analgesia on outcomes following radical cystectomy: A systematic review
|
Rahman, Syed N. |
|
|
39 |
2 |
p. 100-108 |
artikel |
12 |
Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer
|
Onishi, Takehisa |
|
|
39 |
2 |
p. 132.e1-132.e6 |
artikel |
13 |
Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer
|
Maroto, P |
|
|
39 |
2 |
p. 135.e17-135.e23 |
artikel |
14 |
Increased risk of disease progression in younger men: Analysis of factors predicting biochemical failure and castration-resistant prostate cancer after high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer
|
Aizawa, Rihito |
|
|
39 |
2 |
p. 131.e9-131.e15 |
artikel |
15 |
Infectious complications associated with perioperative blood transfusion in partial or radical nephrectomy
|
Hamilton, Zachary A |
|
|
39 |
2 |
p. 134.e17-134.e26 |
artikel |
16 |
Long term outcomes for patients with von Hippel-Lindau and Pheochromocytoma: defining the role of active surveillance
|
Sanford, Thomas |
|
|
39 |
2 |
p. 134.e1-134.e8 |
artikel |
17 |
Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma
|
Abdul-Muhsin, Haidar |
|
|
39 |
2 |
p. 133.e9-133.e16 |
artikel |
18 |
Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors
|
Chahoud, Jad |
|
|
39 |
2 |
p. 134.e9-134.e16 |
artikel |
19 |
Pathologic nodal downstaging in men with clinically involved lymph nodes undergoing radical prostatectomy: Implications for definitive locoregional therapy
|
Ghali, Fady |
|
|
39 |
2 |
p. 130.e1-130.e7 |
artikel |
20 |
Predicting morbidity and mortality after radical cystectomy using risk calculators: A comprehensive review of the literature
|
Razdan, Shirin |
|
|
39 |
2 |
p. 109-120 |
artikel |
21 |
Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict response
|
Ghodoussipour, Saum |
|
|
39 |
2 |
p. 133.e1-133.e8 |
artikel |
22 |
Primary Ta high grade bladder tumors: Determination of the risk of progression
|
Quhal, Fahad |
|
|
39 |
2 |
p. 132.e7-132.e11 |
artikel |
23 |
Risk of renal cancer in patients with inflammatory bowel disease: A pooled analysis of population-based studies
|
Feng, Dechao |
|
|
39 |
2 |
p. 93-99 |
artikel |
24 |
Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
|
Nayak, Brusabhanu |
|
|
39 |
2 |
p. 135.e9-135.e15 |
artikel |
25 |
Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy
|
Prabhu, Nicole |
|
|
39 |
2 |
p. 130.e9-130.e15 |
artikel |
26 |
Surveillance of postchemotherapy subcentimeter residual retroperitoneal mass in metastatic nonseminomatous germ cell tumor: Does how you measure matter?
|
Cotner, Cody E. |
|
|
39 |
2 |
p. 136.e11-136.e17 |
artikel |
27 |
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
|
Pierconti, Francesco |
|
|
39 |
2 |
p. 131.e17-131.e21 |
artikel |
28 |
The effect of centralization of care on overall survival in primary urethral cancer
|
Stone, Benjamin V. |
|
|
39 |
2 |
p. 133.e17-133.e26 |
artikel |
29 |
Urologic Oncology: A Personal History and Lessons Learned
|
Droller, Michael J. |
|
|
39 |
2 |
p. 81-84 |
artikel |